Targeted drug combination therapy design based on driver genes
Targeted drug combination therapy design based on driver genes |
|
https://doi.org/10.18632/oncotarget.26985
Lilian Zsákai,
Anna Sipos,
Judit Dobos,
Dániel Erős,
Csaba Szántai-Kis,
Péter Bánhegyi,
János Pató,
László Őrfi,
Zsolt Matula,
Gábor Mikala,
György Kéri,
István Peták,
and István Vályi-Nagy
|
| 5255-5266 |
Deep insights into the response of human cervical carcinoma cells to a new cyano enone-bearing triterpenoid soloxolone methyl: a transcriptome analysis
Deep insights into the response of human cervical carcinoma cells to a new cyano enone-bearing triterpenoid soloxolone methyl: a transcriptome analysis |
|
https://doi.org/10.18632/oncotarget.27085
Andrey V. Markov,
Alexander E. Kel,
Oksana V. Salomatina,
Nariman F. Salakhutdinov,
Marina A. Zenkova,
and Evgeniya B. Logashenko
|
| 5267-5297 |
Drivers of topoisomerase II poisoning mimic and complement cytotoxicity in AML cells
Drivers of topoisomerase II poisoning mimic and complement cytotoxicity in AML cells |
|
https://doi.org/10.18632/oncotarget.27112
Piyush More,
Ute Goedtel-Armbrust,
Viral Shah,
Marianne Mathaes,
Thomas Kindler,
Miguel A. Andrade-Navarro,
and Leszek Wojnowski
|
| 5298-5312 |
Genome-wide miRNA profiling and pivotal roles of miRs 125a-5p and 17-92 cluster in human neutrophil maturation and differentiation of acute myeloid leukemia cells
Genome-wide miRNA profiling and pivotal roles of miRs 125a-5p and 17-92 cluster in human neutrophil maturation and differentiation of acute myeloid leukemia cells |
|
https://doi.org/10.18632/oncotarget.27123
El-Habib Dakir,
and Faustino Mollinedo
|
| 5313-5331 |
Safety evaluation of conditionally immortalized cells for renal replacement therapy
Safety evaluation of conditionally immortalized cells for renal replacement therapy |
|
https://doi.org/10.18632/oncotarget.27152
Milos Mihajlovic,
Sam Hariri,
Koen C.G. Westphal,
Manoe J. Janssen,
Miriam J. Oost,
Laura Bongiovanni,
Lambertus P. van den Heuvel,
Alain de Bruin,
Luuk B. Hilbrands,
and Rosalinde Masereeuw
|
| 5332-5348 |
Tumor penetrating nanomedicine targeting both an oncomiR and an oncogene in pancreatic cancer
Tumor penetrating nanomedicine targeting both an oncomiR and an oncogene in pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.27160
Maud-Emmanuelle Gilles,
Liangliang Hao,
Kaelyn Brown,
Jihoon Lim,
Sangeeta N. Bhatia,
and Frank J. Slack
|
| 5349-5358 |
Preliminary observations on soluble programmed cell death protein-1 as a prognostic and predictive biomarker in patients with metastatic melanoma treated with patient-specific autologous vaccines
Preliminary observations on soluble programmed cell death protein-1 as a prognostic and predictive biomarker in patients with metastatic melanoma treated with patient-specific autologous vaccines |
|
https://doi.org/10.18632/oncotarget.27164
Robert O. Dillman,
Gabriel I. Nistor,
Bryce T. McLelland,
Candace Hsieh,
Aleksandra J. Poole,
Andrew N. Cornforth,
and Hans S. Keirstead
|
| 5359-5371 |
A novel tumor spheroid model identifies selective enhancement of radiation by an inhibitor of oxidative phosphorylation
A novel tumor spheroid model identifies selective enhancement of radiation by an inhibitor of oxidative phosphorylation |
|
https://doi.org/10.18632/oncotarget.27166
Henning Karlsson,
Wojciech Senkowski,
Mårten Fryknäs,
Sharmineh Mansoori,
Stig Linder,
Joachim Gullbo,
Rolf Larsson,
and Peter Nygren
|
| 5372-5382 |
Correction: Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin’s lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms
Correction: Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin’s lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms |
|
https://doi.org/10.18632/oncotarget.27175
Tri Nguyen,
Rebecca Parker,
Elisa Hawkins,
Beata Holkova,
Victor Yazbeck,
Akhil Kolluri,
Maciej Kmieciak,
Mohamed Rahmani,
and Steven Grant
|
| 5383-5384 |
Correction: Fibroblast growth factor receptor 4 induced resistance to radiation therapy in colorectal cancer
Correction: Fibroblast growth factor receptor 4 induced resistance to radiation therapy in colorectal cancer |
|
https://doi.org/10.18632/oncotarget.27186
Mohamed A. Ahmed,
Edgar Selzer,
Wolfgang Dörr,
Gerd Jomrich,
Felix Harpain,
Gerd R. Silberhumer,
Leonhard Müllauer,
Klaus Holzmann,
Bettina Grasl-Kraupp,
Michael Grusch,
Walter Berger,
and Brigitte Marian
|
| 5385-5386 |
